MD Anderson Cancer Center Overview
- Year Founded
-
1941
- Status
-
Private
- Employees
-
25,000
- Latest Deal Type
-
Grant
- Financing Rounds
-
3
- Investments
-
12
MD Anderson Cancer Center General Information
Description
Provider of cancer treatment services based in Houston, Texas. The company operates as a degree-granting academic institution as well as offers services related to cancer treatment and research.
Contact Information
Website
www.mdanderson.orgCorporate Office
- 1515 Holcombe Boulevard
- Houston, TX 77030
- United States
Corporate Office
- 1515 Holcombe Boulevard
- Houston, TX 77030
- United States
MD Anderson Cancer Center Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MD Anderson Cancer Center Comparisons
Industry
Financing
Details
MD Anderson Cancer Center Competitors (25)
One of MD Anderson Cancer Center’s 25 competitors is Hartford HealthCare, a Corporation company based in Hartford, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hartford HealthCare | Corporation | Hartford, CT | ||||
| NewYork-Presbyterian Hospital | Corporation | New York, NY | ||||
| SSM Health | Corporate Backed or Acquired | Saint Louis, MO | ||||
| Mayo Clinic | Corporation | Rochester, MN | ||||
| Nationwide Children's Hospital | Venture Capital-Backed | Columbus, OH |
MD Anderson Cancer Center Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MD Anderson Cancer Center Patents
MD Anderson Cancer Center Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210137963-A1 | Treatment of aberrant fibroblast proliferation | Active | 08-Nov-2019 | ||
| US-20200390736-A1 | Use of an rxr agonist in treating her2+ cancers | Active | 11-Jun-2019 | ||
| EP-3946419-A4 | Methods of treating cancer with chk1 inhibitors | Pending | 28-Mar-2019 | ||
| EP-3946419-A1 | Methods of treating cancer with chk1 inhibitors | Pending | 28-Mar-2019 | ||
| CA-3135165-A1 | Methods of treating cancer with chk1 inhibitors | Pending | 28-Mar-2019 | A61K31/5377 |
MD Anderson Cancer Center Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MD Anderson Cancer Center Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MD Anderson Cancer Center Investments (12)
MD Anderson Cancer Center’s most recent deal was a Joint Venture with Syena. The deal was made on 10-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Syena | 10-Feb-2023 | Joint Venture | Biotechnology | ||
| Radiopharm Ventures | 13-Sep-2022 | Joint Venture | Biotechnology | ||
| Cell Therapy Manufacturing Center | 13-May-2022 | Joint Venture | Biotechnology | ||
| Bellicum Pharmaceuticals (Manufacturing, Office and Laboratory Facility in Houston, Texas) | 14-Apr-2020 | Corporate Asset Purchase | Buildings and Property | ||
| Optera Therapeutics | 07-Mar-2018 | Joint Venture | Biotechnology |
MD Anderson Cancer Center Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| M. D. Anderson Foundation | Foundation | Houston, TX |
MD Anderson Cancer Center Exits (2)
MD Anderson Cancer Center’s most recent exit was on 07-Mar-2018 from Optera Therapeutics. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Optera Therapeutics | 07-Mar-2018 | Completed |
|
||
| MyRoundUp | 27-Mar-2015 | Seed Round | Completed |
|
MD Anderson Cancer Center FAQs
-
When was MD Anderson Cancer Center founded?
MD Anderson Cancer Center was founded in 1941.
-
Where is MD Anderson Cancer Center headquartered?
MD Anderson Cancer Center is headquartered in Houston, TX.
-
What is the size of MD Anderson Cancer Center?
MD Anderson Cancer Center has 25,000 total employees.
-
What industry is MD Anderson Cancer Center in?
MD Anderson Cancer Center’s primary industry is Hospitals/Inpatient Services.
-
Is MD Anderson Cancer Center a private or public company?
MD Anderson Cancer Center is a Private company.
-
What is MD Anderson Cancer Center’s current revenue?
The current revenue for MD Anderson Cancer Center is .
-
How much funding has MD Anderson Cancer Center raised over time?
MD Anderson Cancer Center has raised $206M.
-
Who are MD Anderson Cancer Center’s investors?
San Antonio Cancer Foundation and Concord Medical Services have invested in MD Anderson Cancer Center.
-
Who are MD Anderson Cancer Center’s competitors?
Hartford HealthCare, NewYork-Presbyterian Hospital, SSM Health, Mayo Clinic, and Nationwide Children's Hospital are some of the 25 competitors of MD Anderson Cancer Center.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
